Developer of drugs designed to improve the limitations of antibody therapeutics and antibody-drug conjugates. The company's drugs detect cancer lesions so that they are absorbed quickly and specifical...

Healthcare
Daejeon, South Korea
Founded 2021
22 employees
Website
Valuation
$0
Share Price
N/A
Total Raised
$33M
Last Round
N/A

Get the full picture

Create a free account to unlock Trioar's funding history, team members, investor details, and more.

15 free profiles/month · No credit card required